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doi:10.1016/j.pedneo.2011.08.004Background: Although significant advances have been made in perinatal care, retinopathy of
prematurity (ROP) remains a serious complication in prematurely born individuals. There have
been limited studies on ROP in Taiwan, and most of those existing reports are outdated.
Methods: This retrospective study included 252 very-low-birth-weight (VLBW) infants admitted
to the neonatal intensive care unit of Chang Gung Children’s Hospital over a 2-year period
between July 2005 and June 2007. All infants were examined for ROP according to the guide-
lines published by the American Academy of Pediatrics. The relationship between clinical risk
factors and the development of ROP was analyzed.
Results: Of the 252 VLBW infants, 216 met the screening criteria. Of the 216, 99 (45.8%) had
ROP. Compared with neonates born at 29 weeks of gestational age (GA) or later, those very
premature infants of 25weeks’ and 26e28 weeks’ GA had increased odds ratios (OR) of
8.49 and 3.19, respectively, for the development of severe ROP. No ROP was detected in
infants of greater than 33 weeks’ GA. The simultaneous presence of a low GA, low birth weight
(LBW), lower Apgar scores, hypotension, patent ductus arteriosus, septicemia, intraventricular
hemorrhage, ventilator dependence, and use of postnatal steroids was associated with severe
ROP. Using multiple logistic regression analyses for ROP, only maternal preeclampsia [OR, 2.52;
confidence interval (CI), 1.32e4.7]; duration of mechanical ventilation (OR, 1.06; CI, 1.04e
1.08); and LBW (OR, 2.62; CI, 1.370e3.375) predicted the development of threshold ROP.eonatology, Department of Pediatrics, Chang Gung Memorial Hospital, Chang Gung University, School
ric Office 12L), Kwei-Shan, Taoyuan, Taiwan.
org.tw (R. Lien).
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322 C.-Y. Yang et alConclusion: The incidence of ROP among VLBW infants was 45.8%; 19.0% had severe ROP.
Infants of lower GAs and/or with LBW, whose mother had preeclampsia or who had a long dura-
tion of mechanical ventilation are at risk for the development of threshold ROP.
Copyright ª 2011, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Retinopathy of prematurity (ROP) is characterized by
abnormal vascular development of the retina in premature
infants.1 Improved neonatal care in Taiwan has increased
the survival of very-low-birth-weight (VLBW) premature
infants and has consequently increased the incidence of
ROP.1e4 ROP is a leading cause of childhood blindness5,6 and
accounts for up to 10% of childhood blindness in developed
countries.7 Nevertheless, there are limited studies on the
incidence and risk factors of this important morbidity
among VLBW infants in Taiwan.1e4 Although significant
advances have been made in perinatal care, ROP remains
a serious complication in prematurely born individuals.8
High-concentration oxygen therapy was previously
thought to be the major contributory factor in the devel-
opment of ROP.9 However, cases of ROP have been reported
without oxygen therapy, and not all premature infants who
receive oxygen therapy develop ROP.10 This suggests that
factors other than oxygen play an important role in the
development of ROP. The last major report on ROP inci-
dence was based on data from the United States National
Inpatient Sample data source, completed in 2009. The total
ROP incidences were 0.17% of all newborn infants and
15.58% of premature infants with a hospital stay longer
than 28 days.11 The objectives of this study were to
determine the incidence of ROP and evaluate the possible
risk factors associated with the severity of ROP among
VLBW infants in northern Taiwan.
2. Materials and Methods
2.1. Patients
This was a retrospective study in which we reviewed the
medical records of all 22-week-old to 36-week-old VLBW
premature infants who were admitted to the neonatal
intensive care unit (NICU) of Chang Gung Children’s
Hospital from July 1, 2005, to June 30, 2007. This was
a Level III nursery in northern Taiwan. There were no
significant changes in referral patterns or in the proportion
of premature infants admitted over the study period.
Of the 2441 infants admitted during the 2-year study
period, 252 were VLBW infants. Of those infants, 216
neonates met the criteria to have their eyes examined by
pediatric ophthalmologists to detect ROP.
2.2. Criteria for eye examination
Eye examinations were performed on all infants who met
the following criteria12: (1) infants with a birth weight (BW)of less than 1500 g or gestational age (GA) of 32 weeks or
less; and (2) infants with a BW between 1500 g and 2000 g or
GA of more than 32 weeks with an unstable clinical course,
including those who required cardiorespiratory support and
who were believed by their attending pediatrician or
neonatologist to be at high risk.
2.3. Follow-up and management of infants at risk of
ROP
If no ROP was noted, eye examinations were continued
every 2 weeks until vascularization had reached Zone 3.
Those with ROP were followed up at intervals indicated by
the severity of the disease. The stages of ROP were clas-
sified according to the International Classification of Reti-
nopathy of Prematurity.13
The zone of vascularization was noted. The number of
total and contiguous clock hours of ROP and the presence or
absence of plus disease (tortuosity of veins) were important
determinants of management. All infants with threshold
ROP were treated with laser therapy using indirect
ophthalmoscopy. No eye shields were used except when
infants were receiving phototherapy. At all times during
NICU care, supplemental oxygen was given to maintain
pulse oximetry between 90% and 95%, and no change in
target oxygen saturation was made based on ROP disease.
All infants on supplemental oxygen during the period of
observation were continuously monitored by pulse
oximetry.
For purposes of data analysis, the infants were divided
into three groups. Group 1 consisted of infants without ROP.
Group 2 consisted of infants with ROP not requiring any
surgery. Group 3 consisted of infants with severe or
threshold ROP requiring laser surgery.
2.4. Identification of risk factors
The following perinatal-neonatal variables were reviewed
for their correlation with the development of ROP reflect-
ing the severity of disease: GA, BW, Apgar scores, type of
delivery, small-for-GA (SGA) status, gender, acidosis, use of
a vasopressor, presence of respiratory distress syndrome
(RDS), use of a surfactant, presence of confirmed sepsis,
patent ductus arteriosus (PDA), intraventricular hemor-
rhage (IVH), periventricular leukomalacia (PVL), necro-
tizing enterocolitis, days on mechanical ventilation, days
on supplemental oxygen, postnatal steroid use, and length
of hospital stay. We also analyzed perinatal variables,
including presence of multiple gestations, maternal
preeclampsia, prolonged rupture of membrane (PROM), and
maternal administration of betamethasone and tocolytic
agents. Because most risk factors were functions of
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designed using the maternal obstetric factors and perinatal
events mentioned earlier.
2.5. Statistical analysis
Statistical analysis was performed using the SPSS program
(SPSS Inc., Chicago, IL, USA). Univariate comparisons of risk
factors among the three groups with and without ROP were
evaluated using Student t test and the Chi-square test as
appropriate, with statistical significance defined as
p< 0.05. Stepwise multivariate logistic regression analysis
was used to evaluate factors predictive of the development
of ROP. The odds ratio (OR) and 95% confidence interval (CI)
for each possible risk factor were also calculated.
3. Results
During the 2-year period, 2441 infants were admitted to the
NICU, of whom 252 were VLBW infants (Figure 1). Of these,
216 VLBW infants met the criteria for ROP screening.
Ninety-nine infants (45.8%) who received eye examination
were diagnosed with ROP of any stage, of whom 41 (19.0%)
had severe ROP (Stage 3 or greater).
3.1. Maternal obstetric factors
Table 1 summarizes the maternal obstetric factors in the
studied infants. Maternal PROM and multiple births were
not significantly different among infants who developed
any stage of ROP and those who had no ROP. Seven (14.5%)Admissions during 
study period  
2441 live births 
VLBW <1500g 
252
ROP diagnosed : 99 No ROP : 117  
Stage 2 ROP : 58 Stage 3 ROP : 41 
Met criteria for eye 
  examination : 216 Died : 36
Figure 1 Schematic diagram of the distribution of infants in
the study. ROPZ retinopathy of prematurity; VLBWZ very low
birth weight.infants without ROP were born to mothers with
preeclampsia, whereas only one (2.4%) infant with ROP
requiring surgery was born to a mother with preeclampsia
(p< 0.01). In our study, most babies born by normal vaginal
delivery were in the group without ROP as opposed to the
babies in the ROP group requiring surgery (pZ 0.025).
Maternal tocolytic agents and antenatal betamethasone
use were similar among the groups.
3.2. Distribution of incidence and stages of ROP
by GA
The incidences of ROP in survivors born at 24 weeks or less,
at 25e27 weeks, at 28e30 weeks, and at 31e33 weeks were
94%, 78%, 47%, and 19%, respectively. In VLBW infants with
a GA of <31 weeks, the incidence of ROP was 50.3% (90 of
179) versus 12.3% (9 of 73) in VLBW infants with a GA 31
weeks (p< 0.0001). No infants born beyond 33 weeks’
gestation had ROP, and 92% of threshold ROP requiring
surgery occurred in infants of less than 30 weeks’ GA at
birth.
Table 2 summarizes the demographic characteristics of
all studied infants. The mean GA of infants without ROP was
higher, at 30.3 2.6 weeks, compared with 26.9 2.1
weeks in infants with ROP requiring surgery (p< 0.05).
3.3. Distribution of stages of ROP by BW
For infants with BW <1000 g, the incidence of ROP of any
degree was 61.3% (54 of 88); of these, 28.4% (25 of 88) had
threshold ROP. The mean BW of infants without ROP was
1251 186 g. The mean BW of infants with ROP not
requiring surgery was 1014 235 g, compared with
954 252 g in infants with ROP requiring surgery (p< 0.05).
3.4. Distribution by intrauterine growth
Thirty percent of the sample (65 of 216) were SGA infants.
In this group, 50.8% (33 of 65) did not have ROP, and 20% (13
of 65) had ROP requiring surgery (pZ 0.367). The incidence
of ROP among SGA infants was not statistically significantly
different from that among non-SGA infants.
3.5. Apgar scores
Infants with ROP requiring surgery had lower 1-minute
Apgar scores compared with infants without ROP (5 2
vs. 7 2, respectively; p< 0.05). Infants with ROP requiring
surgery also had lower 5-minute Apgar scores than those
without ROP (7 2 vs. 8 1, respectively; p< 0.05).
3.6. Clinical characteristics of infants
These clinical characteristics of the infants are summarized
in Table 2. The incidences of hypothermia at birth, male
gender, and necrotizing enterocolitis were not statistically
different in the group without ROP compared with those
with any stage of ROP. Infants with ROP had a higher inci-
dence of RDS, hypotension requiring inotropic support, PDA
requiring indomethacin or ligation, and septicemia
(p< 0.05). The incidence of PDA was 62.2% in the group
Table 1 Maternal and obstetric factors and comparison of variables.
Variable No ROP
(nZ 117)
ROP without
surgery (nZ 58)
ROP with
surgery (nZ 41)
All VLBW with
ROP (nZ 99)
p
n (%) n (%) n (%) n (%)
Maternal PROM 32 (58.1) 12 (21.8)y 11 (20.0)y 23 (41.8) 0.420
Multiple births 38 (55.0) 21 (30.4)y,z 10 (14.5)y 31 (44.9) 0.451
Preeclampsia 7 (46.7) 7 (46.7)z 1 (6.7) 8 (53.3)y 0.010*
Antenatal beta-agonist 69 (52.7) 39 (29.8)y,z 23 (17.6)y 67 (51.1) 0.588
Vaginal delivery 45 (57.0) 13 (16.5)y,z 21 (26.6)y 34 (43.0)y 0.025*
Antenatal betamethasone 72 (57.1) 35 (27.8)y,z 19 (15.1)y 58 (46.0) 0.595
*A p value <0.05, significant.
y ROP with and/or without surgery vs no ROP.
z ROP with surgery vs ROP without surgery.
PROMZ prolonged rupture of membrane; ROPZ retinopathy of prematurity.
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(p< 0.01). Infants who developed any-stage ROP also were
more likely to have IVH and PVL compared with infants
without ROP (p< 0.05).
3.7. Respiratory data of infants
Respiratory data of the infants are summarized in Table 3.
Severity of respiratory disease, reflected by infants with
RDS along with a longer duration of use of mechanical
ventilation, continuous positive airway pressure (CPAP),
and supplemental oxygen, was significantly associated withTable 2 Characteristics of study infants.
Characteristics No ROP
(nZ 117)
ROP without
surgery (nZ 58)
Hypothermia 41 (54.7) 17 (22.7)y
Gestational age (wk) 30.3 2.6 28.1 1.9y
Birth weight (g) 1251 186 1014 235y,z
Apgar 1 min 6.54 1.85 4.91 1.97y
Apgar 5 min 8.30 1.33 7.12 1.49y
SGA 33 (50.8) 19 (29.2)y,z
Boy 55 (50.0) 29 (26.4)y
RDS 69 (44.2) 51 (32.7)y,z
Surfactant given 45 (37.2) 45 (37.2)z
Hypotension 37 (41.1) 32 (35.6)y,z
Patent ductus 28 (37.8) 25 (33.8)y
NEC 5 (50.0) 4 (40.0)y,z
Septicemia 24 (45.3) 19 (35.8)y,z
IVH 5 (20.8) 11 (45.8)y,z
PVL 3 (30.0) 4 (40.0)y,z
Postnatal steroid 5 (27.8) 6 (33.3)y
Length of stay (d) 56 24 80 31y
Data are presented as n (%) or mean standard deviation.
*A p value <0.05, significant.
y ROP with and/or without surgery vs no ROP.
z ROP with surgery vs ROP without surgery.
IVHZ intraventricular hemorrhage; NECZ necrotizing enterocolitis;
syndrome; ROPZ retinopathy of prematurity; SGAZ small for gestatthe incidence and severity of ROP in our study. Similarly, 76
of 121 (62.8%) of the patients with ROP received surfactant
compared with only 45 of 121 (37.2%) in the group without
ROP (p< 0.001).
3.8. Multiple logistic regression analysis
Results of the multiple logistic regression analysis are
shown in Table 4. Only preeclampsia (OR, 2.52; CI,
1.32e4.7); duration of mechanical ventilation (OR, 1.06;
CI, 1.04e1.08); and LBW (OR, 2.62; CI, 1.370e3.375) were
identified as factors predictive of ROP.ROP with
surgery (nZ 41)
All VLBW with
ROP (nZ 99)
p
17 (22.7)y 34 (45.3) 0.285
26.9 2.1y 27.6 2.1y 0.000*
954 252y 989 242y 0.000*
4.95 1.84y 4.93 1.91y 0.000*
6.87 1.64y 7.02 1.54y 0.000*
13 (20.0)y 32 (49.2) 0.367
26 (23.6)y 55 (50.0) 0.345
36 (23.1)y 87 (55.8)y 0.000*
31 (25.6)y 76 (62.8)y 0.000*
21 (23.3)y 53 (58.9)y 0.010*
21 (28.4)y 46 (62.2)y 0.003*
1 (10.0)y 5 (50.0) 0.145
10 (18.9)y 29 (54.7)y 0.035*
8 (33.3)y 19 (79.2) y 0.020*
3 (30.0) 7 (70.0)y 0.008*
7 (38.9)y 13 (72.2)y 0.003*
94 54y 86 42y 0.000*
PVLZ periventricular leukomalacia; RDSZ respiratory distress
ional age.
Table 3 Respiratory data of study infants.
Comparison of respiratory status
among study infants
No ROP
(nZ 117)
ROP without
surgery (nZ 58)
ROP with
surgery (nZ 41)
All VLBW with
ROP (nZ 99)
p
RDS 69 (44.2) 51 (32.7)y,z 36 (23.1)y 87 (55.8)y 0.000*
Surfactant 45 (37.2) 45 (37.2)y 31 (25.6)y 76 (62.8)y 0.000*
ABG pH< 7.2 15 (38.5) 10 (25.6)z 14 (35.9) 24 (61.5)y 0.018*
ABG pCO2< 30 92 (54.8) 45 (26.8)
y,z 31 (18.5)y 76 (45.2)y 0.040*
Ventilator (d) 19.4 21.5 39.9 37.7y,z 48.5 39.3y 46.6 36.6y 0.000*
CPAP (d) 5.4 11.6 14.9 20.2y,z 30.2 27.4y 17.5 21.4y 0.000*
Oxygen (d) 35.0 28.7 71.6 29.9y 96.1 47.2y 81.1 39.2y 0.000*
Data are presented as n (%) or mean standard deviation.
*A p value <0.05, significant.
y ROP with and/or without surgery vs no ROP.
z ROP with surgery vs ROP without surgery.
ABG = arterial blood gas; CPAPZ continuous positive airway pressure; RDSZ respiratory distress syndrome.
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This was a comprehensive study of current incidence, risk
factors, and severity of ROP in one medical center in
Taiwan, where there have been limited studies on ROP. This
study investigated the largest group of VLBW infants with
ROP in Taiwan to date.
In the past decade, the reported incidence of ROP has
varied worldwide, ranging from 10% in Norway to 34% in
Oman.14e16 Recent reports from Europe and Australia sug-
gested a decreasing incidence of severe ROP compared with
that in the previous decade; a decreasing incidence has also
been seen among infants with BW <1000 g.14 In our study,
the overall incidence of ROP in VLBW infants was 45.8% (99
of 216), with 19% of infants having severe (Stage 3 or
greater) ROP. The incidence of ROP varies considerably in
different populations and races in a pattern not easily
explained by differences in neonatal intensive care prac-
tices. In our study, 41% of the VLBW infants with ROP
needed surgery, and this was higher than that in any other
studies. Early treatment for ROP in our hospital resulted in
a higher surgical rate than in any other studies. In our study
and in numerous previous studies, BW was determined to be
an important factor associated with ROP.
4.1. Maternal obstetric factors
A lower rate of vaginal delivery in the ROP group probably
reflected the high-risk perinatal status of these immature
infants at the time of their delivery. Immaturity reflected
by lower BW and GA at birth was a significant factor in
infants who developed ROP.Table 4 Multiple logistic regression of factors.
Comparison of risk factors for
the development of ROP
Odds ratio
Maternal preeclampsia 2.52
Duration of mechanical ventilation 1.06
Birth weight 2.62Antenatal betamethasone has been reported to reduce
the incidence of ROP. Blair et al17 reported a lower ROP
incidence of 36.1% in a Lexington medical center from 1995
to 1997 compared with an international incidence of 57.2%
from the Vermont-Oxford Network Database in 1997
(p< 0.001). Antenatal betamethasone was given to 62.6%
of infants in Blair et al’s study compared with 48.6% in the
Vermont-Oxford Network Database (p< 0.005). In our study
group, 72 of 117 (61.54%) infants without ROP had received
antenatal betamethasone compared with 19 of 41 (46.34%)
infants with threshold ROP (pZ 0.431). Multiple births and
PROM were not significantly different among infants who
developed any stage of ROP and those who did not develop
ROP.
4.2. Gestational age
The mean GA of the screened population in Goble’s study
was 29.1 weeks,18 which was similar to the mean GA of 29.5
weeks in our study. It is recognized that the incidence and
severity of ROP are inversely related to GA and BW. Severe
disease was seen especially in babies with less than 26
weeks’ GA, with severity of disease increasing with
decreasing GA. 19 Infants with a lower GA were more likely
to have been on assisted ventilated for a longer duration
and to develop severe ROP.20 This association was also seen
in our study population.
4.3. Small for GA
It has been reported that infants who are SGA at birth may
be more likely to develop ROP.20,21 This could not be95% Confidence interval p
1.32e4.7 <0.001
1.04e1.08 <0.001
1.370e3.375 <0.001
326 C.-Y. Yang et alconfirmed by the analysis of our data. We believe that the
cause, rather than the condition, of growth retardation may
be a more important factor. This association needs to be
studied in a larger population base stratified by the causes of
growth retardation before any conclusions can be drawn.
4.4. Clinical factors
The data of this study suggest that the severe ROP group had
statistically significant lower BWs, GAs, and Apgar scores;
greater RDS, surfactant usage, hypotension, PDA, culture-
positive septicemia, IVH, and postnatal steroid usage; and
longer durations of oxygen, mechanical ventilation, and
CPAP. Bassiouny16 reported that lower BW and GA and
greater apnea, blood transfusion, mechanical ventilation,
metabolic acidosis, total parenteral nutrition, IVH, and
sepsis were associated with the development of ROP.
Akkoyun et al22 reported that BW and RDS were independent
risk factors in the development ofmild ROP, and that BWwas
a risk factor in the development of severe ROP.
Severity of respiratory disease, reflected by the number
of infants who developed RDS requiring a surfactant, venti-
lator, CPAP, or supplemental oxygen support, was also
significantly higher in those who developed ROP. These
factors have been implicated from the earliest reports link-
ing ROP with oxygen use. Infants who were diagnosed with
ROP also developed more IVH and PVL.
Using stepwise logistic regression analysis, maternal
preeclampsia (OR, 2.52; 95% CI, 1.32e4.7; p< 0.001);
duration of MV; and BW were identified as factors predictive
of ROP in the present study. Menzies et al23 reported a similar
association between preeclampsia and ROP. However, the
effect of maternal hypertension on fetal and subsequent
infant retinal vascularization needs further evaluation. The
duration of oxygen therapy and concentration of oxygen
delivered are directly related to the duration of ventilation.
All of these factors are related to the presence of RDS and the
development of chronic lung disease.
Clinicians should be aware of the presence of these
additional risk factors when caring for premature infants.
The analysis of risk factors for ROP development will help
to understand and predict ROP development in premature
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